Discover world-class research facilities, expertise, and a collaborative ecosystem
Home > Sectors > Life Sciences > Drug Research and Development
The Edmonton Region is at the forefront of research in cancer, virology, precision health, diabetes, artificial intelligence, and more – with world class facilities to support this work.
The Region is home to some impressive research institutes including the Li Ka Shing Applied Virology Institute, a world leader in virology research and vaccine development, as well as the Alberta Diabetes Institute, which is leading in the cure and treatment of diabetes. The University of Alberta is also home to the largest consortium of virologists in Canada.
The Edmonton Region is a hotbed of scientific discovery and innovation, where world-class researchers, state-of-the-art facilities, and a thriving collaborative ecosystem converge to drive the future of drug research and development.
Our commitment to pushing the boundaries of science is evident in our world-class research institutions, partnerships with industry leaders, and cutting-edge AI capabilities. This unique environment provides unparalleled opportunities for companies seeking to accelerate their drug discovery and development initiatives.
Access state-of-the-art laboratories, including the University of Alberta's Drug Development and Innovation Centre and collaborate with renowned researchers in diverse therapeutic areas.
Benefit from partnerships with research institutions, industry leaders, and government organizations like Alberta Innovates and the National Research Council of Canada.
The Edmonton Region is home to the Alberta Machine Intelligence Institute, which is working with industry to speed up drug discovery, drive efficiencies, and improve patient outcomes.
Discover organizations and businesses that are driving innovation and growth in drug discovery
The LKSIoV unites a consortium of world-renowned researchers to promote scientific advancements aimed at expanding understanding of virology and immunology.
The 25,000 square foot Institute was established in 2007 as a stand-alone facility to consolidate the University of Alberta’s outstanding collection of diabetes researchers and their trainees.
As part of Alberta Health Services, the Cross Cancer Institute (CCI) is a leader in innovative cancer research, prevention, treatment and care. The Institute includes an active clinical trials unit and state-of-the-art care and equipment.
DrugBank is the world’s first and largest intelligent and comprehensive drug knowledge platform. With the help of artificial intelligence, DrugBank gathers, authors, verifies, and structures all of the latest biomedical information into one platform.
48Hour Discovery is a company with a dynamic peptide discovery platform that has revolutionized peptide discovery through its highly customizable approach to chemically modified phage display. Leveraging their cutting-edge technologies, the platform accelerates the identification and optimization of peptides with therapeutic potential, offering a novel pathway to addressing unmet medical needs.
North American Free Trade Agreement or Canada-United States-Mexico
The Comprehensive Economic and Trade Agreement with the European Union
The Comprehensive an Progressive Agreement for Trans-Pacific Partnership
If you have any questions, require further information, or would like to book a consultation, please send us a message.
Senior Manager, Business Development, Life sciences
